148 related articles for article (PubMed ID: 38689248)
1. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract][Full Text] [Related]
2. [Curative effect analysis of postoperative concurrent chemoradiotherapy on early-stage cervical cancer patients with intermediate-risk factors].
Tang Q; Tu YQ; Chen JH; Lyu XJ; Yan DD
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):462-466. PubMed ID: 29936774
[No Abstract] [Full Text] [Related]
3. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.
Kim H; Park W; Kim YS; Kim YJ
J Gynecol Oncol; 2020 May; 31(3):e35. PubMed ID: 31912685
[TBL] [Abstract][Full Text] [Related]
5. 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
Song S; Song C; Kim HJ; Wu HG; Kim JH; Park NH; Song YS; Kim JW; Kang SB; Ha SW
Gynecol Oncol; 2012 Jan; 124(1):63-7. PubMed ID: 22004904
[TBL] [Abstract][Full Text] [Related]
6. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.
Mabuchi S; Morishige K; Isohashi F; Yoshioka Y; Takeda T; Yamamoto T; Yoshino K; Enomoto T; Inoue T; Kimura T
Gynecol Oncol; 2009 Dec; 115(3):482-7. PubMed ID: 19783286
[TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
[TBL] [Abstract][Full Text] [Related]
10. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
11. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study.
Sun HY; Tang Q; Chen JH; Lv XJ; Tu YQ; Yan DD
Onco Targets Ther; 2018; 11():1149-1155. PubMed ID: 29563803
[TBL] [Abstract][Full Text] [Related]
13. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Sequential Chemoradiation vs Concurrent Chemoradiation or Radiation Alone in Adjuvant Treatment After Hysterectomy for Cervical Cancer: The STARS Phase 3 Randomized Clinical Trial.
Huang H; Feng YL; Wan T; Zhang YN; Cao XP; Huang YW; Xiong Y; Huang X; Zheng M; Li YF; Li JD; Chen GD; Li H; Chen YL; Ma LG; Yang HY; Li L; Yao SZ; Ye WJ; Tu H; Huang QD; Liang LZ; Liu FY; Liu Q; Liu JH
JAMA Oncol; 2021 Mar; 7(3):361-369. PubMed ID: 33443541
[TBL] [Abstract][Full Text] [Related]
15. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Oh YT; Kang SH
BMC Cancer; 2017 Apr; 17(1):297. PubMed ID: 28454573
[TBL] [Abstract][Full Text] [Related]
19. Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
Kim H; Cho WK; Kim YJ; Kim YS; Park W
Gynecol Oncol; 2020 May; 157(2):423-428. PubMed ID: 32139148
[TBL] [Abstract][Full Text] [Related]
20. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
